Cargando…
Cerebrospinal fluid biomarkers in SARS-CoV-2 patients with acute neurological syndromes
BACKGROUND AND PURPOSE: Mechanisms underlying acute brain injury in SARS-CoV-2 patients remain poorly understood. A better characterization of such mechanisms remains essential to preventing long-term neurological sequelae. Our present aim was to study a panel of biomarkers of neuroinflammation and...
Autores principales: | Chaumont, H., Kaczorowski, F., San-Galli, A., Michel, P.P., Tressières, B., Roze, E., Quadrio, I., Lannuzel, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Masson SAS.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708608/ https://www.ncbi.nlm.nih.gov/pubmed/36610823 http://dx.doi.org/10.1016/j.neurol.2022.11.002 |
Ejemplares similares
-
Mixed central and peripheral nervous system disorders in severe SARS-CoV-2 infection
por: Chaumont, H., et al.
Publicado: (2020) -
Long-term outcomes after NeuroCOVID: A 6-month follow-up study on 60 patients
por: Chaumont, H., et al.
Publicado: (2022) -
Serum and cerebrospinal fluid biomarker profiles in acute SARS-CoV-2-associated neurological syndromes
por: Paterson, Ross W, et al.
Publicado: (2021) -
Acute meningoencephalitis in a patient with COVID-19
por: Chaumont, H., et al.
Publicado: (2020) -
Cerebrospinal fluid biomarkers in various pediatric neurologic diseases
por: Lee, Jeongho
Publicado: (2022)